We’re delighted to announce that PHARMExcel has been awarded the prestigious Investors in People (IIP) Gold Standard. This distinguished accreditation is a testament to the company’s unwavering commitment to cultivating a dynamic, supportive, and quality driven workplace culture.
Only 26% of IIP accredited organisations reach the gold standard, so the team are proud and excited about its achievement.
Attaining the Investors in People Gold Standard is a significant milestone for PHARMExcel which highlights its dedication to nurturing its workforce and fostering an environment that values employee well-being and professional development. The rigorous assessment process involved an in-depth evaluation of the company’s practices, policies, and the overall employee experience, demonstrating a comprehensive alignment with the highest global standards of people management.
Paul Devoy, CEO of Investors in People, said: “We’d like to congratulate PHARMExcel. Gold accreditation is a fantastic effort for any organisation, and places PHARMExcel in fine company with a host of organisations that understand the value of people.”
PHARMExcel has long prioritised the growth and development of its employees, recognising them as the backbone of the organisation’s success. Being a smaller CRO in the industry means its operational team has the opportunity to deep dive into a diverse range of studies and research areas relatively quickly in their careers; the company also encourages employees to gain experience in broader projects across the business further developing their technical skills and capabilities.
Overall, the main areas of strength for PHARMExcel were acknowledged in the progress the company has made in:
We’re particularly pleased to have received such great feedback from our staff survey with over 87% agreeing that:
The Investors in People Gold Standard not only underscores PHARMExcel’s commitment to its employees but also highlights the benefits that this achievement brings to its valued clients:
Businesses that achieve Gold accreditation by IIP typically experience a multitude of benefits, including enhanced productivity, improved project management, and strengthened communication. For PHARMExcel’s customers and partners, this accreditation translates into:
Dani Harrison, Head of People and Culture at PHARMExcel expressed great pride in the company’s achievement, stating, “Being awarded gold accreditation is an incredible achievement. It’s been a 3-year journey to get to this result and despite some challenging times we scored above the IIP average in the company survey. To be recognised publicly is testament to PHARMExcel’s commitment in investing in our people and recognising their invaluable contributions “.
Yvanne Enever, CEO at PHARMExcel said; “Congratulations to everyone, it’s an amazing achievement. However, we’re not going to stop here. We’re going to continue to work hard to create a culture and workplace where our people thrive and excel.”
With the Investors in People Gold Standard accreditation, PHARMExcel reaffirms its position as a people-centric CRO, setting a positive example in the clinical research industry for quality driven practices that drive organisational success and fosters lasting client relationships.
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Katie Howe, Head of Marketing
T: +44 (0)20 3642 6654